Detalhe da pesquisa
1.
Olaparib in patients with metastatic castration-resistant prostate cancer with DNA repair gene aberrations (TOPARP-B): a multicentre, open-label, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 162-174, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31806540
2.
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap).
Int J Cancer
; 143(10): 2584-2591, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30006930
3.
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
N Engl J Med
; 373(18): 1697-708, 2015 Oct 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-26510020
4.
Upregulation of GALNT7 in prostate cancer modifies O-glycosylation and promotes tumour growth.
Oncogene
; 42(12): 926-937, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36725887
5.
Elucidating Prostate Cancer Behaviour During Treatment via Low-pass Whole-genome Sequencing of Circulating Tumour DNA.
Eur Urol
; 80(2): 243-253, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34103179
6.
HER3 Is an Actionable Target in Advanced Prostate Cancer.
Cancer Res
; 81(24): 6207-6218, 2021 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34753775
7.
Clinical Utility of Circulating Tumour Cell Androgen Receptor Splice Variant-7 Status in Metastatic Castration-resistant Prostate Cancer.
Eur Urol
; 76(5): 676-685, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31036442
8.
Circulating tumor cells, tumor-derived extracellular vesicles and plasma cytokeratins in castration-resistant prostate cancer patients.
Oncotarget
; 9(27): 19283-19293, 2018 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29721202
9.
EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients.
Oncotarget
; 9(86): 35705-35716, 2018 Nov 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30479699
10.
Single-Cell Analyses of Prostate Cancer Liquid Biopsies Acquired by Apheresis.
Clin Cancer Res
; 24(22): 5635-5644, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30093450
11.
Circulating Cell-Free DNA to Guide Prostate Cancer Treatment with PARP Inhibition.
Cancer Discov
; 7(9): 1006-1017, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28450425